$9.65
0.00%
NYSE, Aug 30, 01:00 am CET
ISIN
US30050B1017
Symbol
EVH

Evolent Health Inc Class A Stock price

$9.65
+0.24 2.55% 1M
+0.66 7.34% 6M
-1.60 14.22% YTD
-22.21 69.71% 1Y
-26.78 73.51% 3Y
-4.68 32.66% 5Y
-7.35 43.24% 10Y
-9.21 48.83% 20Y
NYSE, Closing price Fri, Aug 29 2025
+0.01 0.10%
ISIN
US30050B1017
Symbol
EVH

Key metrics

Basic
Market capitalization
$1.1b
Enterprise Value
$1.8b
Net debt
$669.6m
Cash
$151.0m
Shares outstanding
115.9m
Valuation (TTM | estimate)
P/E
negative | 36.2
P/S
0.5 | 0.6
EV/Sales
0.8 | 0.9
EV/FCF
negative
P/B
1.0
Financial Health
Equity Ratio
46.8%
Return on Equity
-7.8%
ROCE
0.2%
ROIC
0.2%
Debt/Equity
0.7
Financials (TTM | estimate)
Revenue
$2.2b | $1.9b
EBITDA
$109.6m | $152.9m
EBIT
$3.4m | $86.5m
Net Income
$-185.2m | $30.9m
Free Cash Flow
$-63.1m
Growth (TTM | estimate)
Revenue
-6.7% | -24.0%
EBITDA
-8.0% | 32.0%
EBIT
239.1% | 3,452.8%
Net Income
-74.4% | 133.1%
Free Cash Flow
-141.8%
Margin (TTM | estimate)
Gross
16.4%
EBITDA
5.0% | 7.9%
EBIT
0.2%
Net
-8.4% | 1.6%
Free Cash Flow
-2.9%
More
EPS
$-1.6
FCF per Share
$-0.5
Short interest
17.7%
Employees
5k
Rev per Employee
$570.0k
Show more

Is Evolent Health Inc Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Evolent Health Inc Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Evolent Health Inc Class A forecast:

16x Buy
89%
2x Hold
11%

Analyst Opinions

18 Analysts have issued a Evolent Health Inc Class A forecast:

Buy
89%
Hold
11%

Financial data from Evolent Health Inc Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
2,196 2,196
7% 7%
100%
- Direct Costs 1,837 1,837
4% 4%
84%
359 359
18% 18%
16%
- Selling and Administrative Expenses 251 251
14% 14%
11%
- Research and Development Expense - -
-
-
110 110
8% 8%
5%
- Depreciation and Amortization 106 106
13% 13%
5%
EBIT (Operating Income) EBIT 3.36 3.36
239% 239%
0%
Net Profit -185 -185
74% 74%
-8%

In millions USD.

Don't miss a Thing! We will send you all news about Evolent Health Inc Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Evolent Health Inc Class A Stock News

Positive
Seeking Alpha
12 days ago
Evolent's revenue dip in Q1 was structural, not demand-driven, and Q2 shows stabilization; I expect growth to resume in the second half of 2025. New specialty contracts, incremental member growth, and key leadership appointments should drive recovery and enhance clinical and financial credibility. The oversubscribed convertible notes offering signals investor confidence, strengthens liquidity, ...
Neutral
PRNewsWire
14 days ago
WASHINGTON , Aug. 19, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions ("Evolent"), today announced the pricing of $145.0 million aggregate principal amount of 4.50% convertible senior notes due 2031. The notes are being offered only to persons reasonably believed to be qualified institutional buyers ...
Neutral
PRNewsWire
15 days ago
WASHINGTON , Aug. 18, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions ("Evolent"), today announced that it intends to offer $140.0 million aggregate principal amount of convertible senior notes due 2031, subject to market and other conditions. Evolent also expects to grant the initial purchasers in t...
More Evolent Health Inc Class A News

Company Profile

Evolent Health, Inc. engages in the provision of health care delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration. It operates through Services and True Health segments. The Services segment includes clinical and administrative solutions such as total cost of care management and specialty care management and comprehensive health plan administrative services. The True Health segment offers a physician-led health plan for employer-sponsored health coverage. The company was founded by Frank J. Williams, Seth B. Blackley, and Thomas Peterson III in August 2011 and is headquartered in Arlington, VA.

Head office United States
CEO Seth Blackley
Employees 4,500
Founded 2011
Website www.evolent.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today